Cautionary statement 2024 Annual Report 2024 iXBRL viewer Annual Report 2024 ESEF 2024 Annual Report on Form 20-F 2024 provided further evidence that Emma and her executive team have seized the opportunity of the demerger to make fundamental improvements to GSK’s operational performance, comp...
2024 full year and fourth quarter announcement We announced our full year and fourth quarter 2024 results on Wednesday 5 February. Access our full year and fourth quarter results and latest Annual Report below.FY 2024 results Annual Report 2024 ...
Responsible Business Performance Report 2024 Annual Report 2024 Materiality assessment Basis of reporting environmental data 2024 Basis of reporting for social and governance 2024 Our position on Learn more about our views and our practices across a range of access, R&D, intellectual property, ...
Annual reportsView our annual reports dating back to 2005 and information about our Annual General Meetings (AGMs).2023 - 2024DetailsView 99th GSK AGM Transcript PDF (348 KB) Annual General Meeting 2024 VIDEO Annual Report 2023-24 PDF (7.03 MB) | FLIPBOOK...
GSK Pakistan Annual Report 2024 Quarterly results You might also like Our products We research and develop a broad range of innovative products Pharmaceuticals and Vaccines Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to ma...
2006 to 2024 Supplementary notes This statistic was assembled from several editions of the GSK Annual Report. * Reflects the spin-off of the Consumer Healthcare business. Open this statistic in... Spanish Citation formats Citation formats View options Other statistics on the topicPharmaceutical ...
Annual Report Global behind the science magazine GSK Global homepage Global investors Global mediaContinue to Company GSK This is our US website, intended for US audiences only. Other market sites can be reached by visiting our location selector.©...
We've published our 2023 Annual Report and ESG Performance Report London 1,790.09 GBp -22.41 Share price at 16 May 2024 11:38 Go to calculator NYSE 45.70 USD +0.04 Share price at 15 May 2024 16:00 Go to calculator INVESTORS We announced our first quarter 2024 results on Wednesda...
We've published our 2023 Annual Report and ESG Performance Report London 1,650.50 GBp +35.50 Share price at 05 June 2024 17:15 Go to calculator NYSE 41.97 USD +0.62 Share price at 05 June 2024 12:47 Go to calculator INVESTORS We announced our first quarter 2024 results on Wednes...
, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D “Risk factors” in GSK’s Annual Report on Form 20-F for 2023, and GSK’s Q3...